ELEVAI Labs Inc. ELAB 深 沪
已收盘 12-19 16:00:00 美东时间
2.26
+0.080
+3.67%
华盛通- 最 高5.60
- 今 开2.22
- 成交量 8.82万股
- 最 低 2.05
- 昨 收 2.18
- 总市值 0
- 52周最高 11.12
- 市盈率 静 --
- 换手率 Infinity.00%
- 52周最低 0.6273
- 委 比 63.56%
- 总股本 --
- 历史最高 11.12
- 量 比 0.05
- 振 幅 162.84%
- 历史最低 0.0125
- 每 手 1
- 风险率 1.66%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多PMGC Capital LLC Urges Alaunos Therapeutics (NASDAQ: TCRT) to Accept Term Sheet from Leading Wall Street Bank Behind Many Leading Crypto Strategies
PMGC Capital urge Alaunos Therapeutics to accept a Wall Street bank-backed financing offer, calling it a strategic opportunity to create value for shareholders.
06-18 13:52
Northstrive Biosciences Announces Initiation of Phase II of Collaboration to Develop AI Powered Therapies for Obesity and Cardiometabolic Diseases
Northstrive Biosciences and Yuva Biosciences have launched Phase II of their AI Development Program, utilizing MitoNova™ to identify small molecule candidates that enhance mitochondrial health in obesity and cardiac diseases. This collaboration aims to develop innovative pharmaceutical treatments for related conditions.
06-17 13:04
PMGC Holdings Inc. Signs Letter of Intent to Acquire Profitable U.S.-Based AS9100D & ISO 9001:2015 Certified CNC Machine Shop Serving Aerospace, Defense, and Industrial Markets for over 35 years
PMGC Holdings Inc. has signed a non-binding Letter of Intent (LOI) to acquire a California-based CNC machining company specializing in precision milling, turning, mold manufacturing, and exotic metals for aerospace, defense, and industrial markets, aligning with its strategic focus.
06-16 12:00
PMGC Holdings Inc. Signs Letter of Intent to Acquire Profitable U.S.-Based Electronics Manufacturing Company
PMGC Holdings Inc. has signed a non-binding Letter of Intent to acquire a U.S.-based electronics contract manufacturing company with over 40 years of history, specializing in high-precision electrical and mechanical assembly. This is the company's second acquisition since April, reflecting its active M&A strategy. The target company generated $699,000 in revenue and $173,000 in adjusted EBITDA in 2024.
06-09 12:00
NorthStrive Biosciences Announces Completion of Phase I Strategic Review for EL-22 Targeting Muscle Loss Associated with GLP-1 Weight Loss Drugs and Age-Related Sarcopenia
Northstrive Biosciences Inc. announces completion of Phase I research for its first-in-class oral myostatin-engineered probiotic, EL-22, targeting muscle-wasting conditions, including GLP-1-associated atrophy. Key findings include strong preclinical rationale and unique oral vaccine approach. The company plans Phase 2 trial for GLP-1 users and regulatory engagement for IND filing.
05-22 12:16
Dow Gains Over 50 Points; Elevai Labs Shares Plummet
U.S. stocks traded higher toward the end of trading, with the Dow Jones index g...
2024-09-24 02:35
Why Elevai Labs (ELAB) Stock Is Down 60% Today
Elevai Labs shares are trading lower by 60% Monday morning. The company announced the pricing of an $8.0 million public offering.
2024-09-23 23:08
Elevai Labs Inc. Announces Pricing Of $8M Public Offering Of 28,571,425 Shares Of Common Stock (Or Pre-Funded Warrants In Lieu Of Shares Of Common Stock). Each Share Of Common Stock Or Pre-Funded Warrant Will Be Sold With One Series A Warrant To Purchase One Share Of Common Stock At An Exercise Price Of $0.38/Share
Elevai Labs, Inc. (NASDAQ:ELAB) ("Elevai" or the "Company"), a pioneering force in medical aesthetics, today announced that it has priced a public offering with gross proceeds to the Company expected to be
2024-09-23 20:47
Elevai Labs Says Study of Exosome Technology Shows Reversal of Hair Thinning; Shares Rise Pre-Bell
08:29 AM EDT, 09/03/2024 (MT Newswires) -- Elevai Labs (ELAB) said Tuesday that a study showed the potential of its exosome technology in reversing hair thinning and inflammation in participants experiencing hair loss or hair thinning. The company said participants were given in-office treatment com...
2024-09-03 20:29
12 Consumer Staples Stocks Moving In Monday's After-Market Session
Gainers Farmmi (NASDAQ:FAMI) stock rose 8.7% to $0.23 during Monday's after-market session. The market value of their outstanding shares is at $2.4 million. S&W Seed (NASDAQ:SANW) shares moved upwards by 8.65% to $0.3. The market value of their outstanding shares is at $13.0 million. Reborn Coffee (...
2024-09-03 04:31
